Drug Shortage Report for NALOXONE HYDROCHLORIDE INJECTION USP

Last updated on 2019-01-31
Report ID 65888
Drug Identification Number 02382482
Brand name NALOXONE HYDROCHLORIDE INJECTION USP
Common or Proper name NALOXONE HYDROCHLORIDE INJECTION
Company Name TELIGENT OU
Active Ingredient(s) NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1 ML
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2018-10-30
Estimated end date 2019-04-30
Actual end date
Shortage status Actual shortage
Updated date 2019-01-31
Company comments
Health Canada comments
Company contact information Call toll free: 1-800-656-0793 or Email: communications@teligent.com / Appeler sans frais au 1-800-656-0793 ou envoyer un courriel à communications@teligent.com